St. Jude bird flu vaccine test successful

May 2, 2006

U.S. scientists say a commercially developed vaccine has successfully protected mice and ferrets against a highly lethal avian influenza virus.

The research, conducted at St. Jude Children's Research Hospital in Memphis, Tenn., involved a vaccine developed by Vical Inc. of San Diego, Calif.

Richard Webby, an assistant faculty member in St. Jude's infectious diseases department, said the finding, coupled with results of previous studies, suggests such a vaccine would protect humans against multiple variants of the bird and human influenza viruses, including the H5N1 virus that might mutate so it can spread readily from person to person.

Flu experts and public health officials fear such an H5N1 variant would trigger a human pandemic.

Webby was to present the study Wednesday in Denver, Colo., during a U.S. Public Health Service Professional Conference.

Copyright 2006 by United Press International

Explore further: Your birth year predicts your odds if flu pandemic were to strike

Related Stories

Recommended for you

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.